On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

The PBMs say out-of-pocket insulin costs have fallen sharply since 2019. The Pharmaceutical Care Management Association, ...

Ted Okon, MBA, executive director of the Community Oncology Alliance, spoke with The American Journal of Managed Care® about how the Federal Trade Commission's (FTC) lawsuit against pharmacy benefit ...

The government’s antitrust watchdog on Friday sued three massive health conglomerates, accusing their drug middlemen of ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

Headquartered in North St. Louis County, Express Scripts, a subsidiary of The Cigna Group, is demanding the FTC retract a ...

The Federal Trade Commission has sued the three largest prescription drug benefit managers (PBMs) and their affiliated group purchasing organizations for engaging in anticompetitive and unfair rebatin ...

The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...

The Federal Trade Commission is suing the titans of the pharmacy benefit ... “As the complaint explains, the PBMs have ...

The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.